Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.55 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.55 |
| ▸ | NAMPT | P43490 | 11/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15344352 | 0.95 | EPHX2 (0.53) | EPHX2NR1H4NAMPTHDAC1HDAC6 | |
| SCHEMBL15344406 | 0.94 | EPHX2 (0.52) | EPHX2NR1H4NAMPTHDAC1HDAC6 | |
| SCHEMBL15344407 | 0.93 | NAMPT (0.60) | EPHX2NR1H4NAMPTHDAC1HDAC6 | |
| SCHEMBL21661941 | 0.87 | HDAC6 (0.63) | EPHX2NR1H4NAMPTHDAC1HDAC6 | |
| SCHEMBL23899245 | 0.84 | NAMPT (0.72) | EPHX2NR1H4NAMPTHDAC1HDAC6 | |
| SCHEMBL31396783 | 0.81 | HDAC1 (0.58) | EPHX2NR1H4NAMPTHDAC1HDAC6 | |
| SCHEMBL24891652 | 0.80 | NAMPT (0.66) | EPHX2NR1H4NAMPTHDAC1HDAC6 | |
| SCHEMBL23899122 | 0.80 | NAMPT (0.66) | EPHX2NR1H4NAMPTHDAC1HDAC6 | |
| SCHEMBL4922883 | 0.80 | NAMPT (0.63) | NAMPTHDAC1NPC1 | |
| SCHEMBL8258345 | 0.79 | NAMPT (0.59) | NAMPTHDAC1HDAC6NPC1TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9084735-B2 | Self-assembling bis-urea compounds for drug delivery | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2015-07-21 | — | — | US | disclosed |
| US-20150037390-A1 | SELF-ASSEMBLING BIS-UREA COMPOUNDS FOR DRUG DELIVERY | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-02-05 | — | — | US | disclosed |
| US-8921426-B2 | Cationic bis-urea compounds as effective antimicrobial agents | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2014-12-30 | — | — | US | disclosed |
| US-20130281515-A1 | CATIONIC BIS-UREA COMPOUNDS AS EFFECTIVE ANTIMICROBIAL AGENTS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130281515-A1 | CATIONIC BIS-UREA COMPOUNDS AS EFFECTIVE ANTIMICROBIAL AGENTS | NOS3, NOS1, NOS2 | EPHX2 4201/4885NR1H4 2240/4885NAMPT 3268/4885 |
| US-20150037390-A1 | SELF-ASSEMBLING BIS-UREA COMPOUNDS FOR DRUG DELIVERY | SLC14A1, NONO, PUF60 | EPHX2 2799/4885NR1H4 480/4885NAMPT 4199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.